These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 35303065

  • 1. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
    Savelkoul EHJ, Maas MHJ, Bourgonje AR, Crouwel F, Biemans VBC, den Broeder N, Russel MGVM, Römkens TEH, de Boer NK, Dijkstra G, Hoentjen F.
    J Crohns Colitis; 2022 Sep 08; 16(9):1372-1379. PubMed ID: 35303065
    [Abstract] [Full Text] [Related]

  • 2. A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients.
    Biemans VBC, Savelkoul E, Gabriëls RY, Simsek M, Dijkstra G, Pierik MJ, West RL, de Boer NKH, Hoentjen F.
    Aliment Pharmacol Ther; 2020 Jun 08; 51(11):1076-1086. PubMed ID: 32339331
    [Abstract] [Full Text] [Related]

  • 3. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
    Atia O, Friss C, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Matz E, Dotan I, Turner D.
    J Crohns Colitis; 2023 Nov 08; 17(10):1614-1623. PubMed ID: 37099729
    [Abstract] [Full Text] [Related]

  • 4. Remission maintenance by tioguanine in chronic active Crohn's disease.
    Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1459-64. PubMed ID: 12823147
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr 15; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
    Mesonero F, Castro-Poceiro J, Benítez JM, Camps B, Iborra M, López-García A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollón F, Rodríguez C, Antolín B, Busquets D, Hernández A, Rivero M, Monfort I Miquel D, Castaño-García A, Gisbert JP, Domènech E, López-Sanromán A, ENEIDA Project of GETECCU.
    Aliment Pharmacol Ther; 2021 May 15; 53(9):1021-1029. PubMed ID: 33715177
    [Abstract] [Full Text] [Related]

  • 7. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 8. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1269-76. PubMed ID: 15191508
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 10. Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.
    Simsek M, Deben DS, Horjus CS, Bénard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA.
    Aliment Pharmacol Ther; 2019 Jul 12; 50(1):54-65. PubMed ID: 31094013
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Wang Y, MacDonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2014 Aug 26; 2014(8):CD006884. PubMed ID: 25157445
    [Abstract] [Full Text] [Related]

  • 12. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries.
    Kante B, Vuyyuru SK, Kedia S, Sahu P, Kumar P, Ranjan MK, Virmani S, Sharma R, Madhusudhan KS, Panwar R, Das P, Makharia G, Ahuja V.
    Indian J Gastroenterol; 2022 Aug 26; 41(4):343-351. PubMed ID: 35997952
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC.
    Aliment Pharmacol Ther; 2012 Jan 26; 35(2):284-91. PubMed ID: 22112005
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
    Bayoumy AB, van Liere ELSA, Simsek M, Warner B, Loganayagam A, Sanderson JD, Anderson S, Nolan J, de Boer NK, Mulder CJJ, Ansari A.
    BMC Gastroenterol; 2020 Sep 11; 20(1):296. PubMed ID: 32917155
    [Abstract] [Full Text] [Related]

  • 15. High variation of tioguanine absorption in patients with chronic active Crohn's disease.
    Deibert P, Dilger K, Fischer C, Hofmann U, Nauck S, Stoelben S, Kreisel W.
    Aliment Pharmacol Ther; 2003 Jul 15; 18(2):183-9. PubMed ID: 12869078
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec 15; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 17. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Vasudevan A, Raghunath A, Anthony S, Scanlon C, Sparrow MP, Gibson PR, van Langenberg DR.
    Dig Dis Sci; 2019 Jun 15; 64(6):1622-1631. PubMed ID: 30560332
    [Abstract] [Full Text] [Related]

  • 18. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
    Schröder O, Blumenstein I, Stein J.
    Eur J Gastroenterol Hepatol; 2006 Jan 15; 18(1):11-6. PubMed ID: 16357613
    [Abstract] [Full Text] [Related]

  • 19. Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease.
    Vasudevan A, Parthasarathy N, Con D, Nicolaides S, Apostolov R, Chauhan A, Bishara M, Luber RP, Joshi N, Wan A, Rickard JA, Long T, Connoley D, Sparrow MP, Gibson PR, van Langenberg DR.
    Aliment Pharmacol Ther; 2020 Oct 15; 52(7):1174-1184. PubMed ID: 32794599
    [Abstract] [Full Text] [Related]

  • 20. Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease.
    Seinen ML, Ponsioen CY, de Boer NK, Oldenburg B, Bouma G, Mulder CJ, van Bodegraven AA.
    Clin Gastroenterol Hepatol; 2013 Jun 15; 11(6):667-72. PubMed ID: 23333660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.